Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Monday, April 14, 2025 1 min read

Key Takeaway: Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Full Press Release Details

Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).